Early time treatments with TBr also demonstrated a clear inhibitory effect on the expression of phosphorylated STAT3 and STAT5 in other leukemia cell lines MOLT-4 and K-562 (Fig. 3C). This evidence concerns the gene STAT3 and leukemia.